DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer

Conditions:   Squamous Cell Carcinoma of the Oral Cavity and Oropharynx;   Oral Mucositis
Interventions:   Drug: SGX942;   Drug: Placebo
Sponsor:   Soligenix
Recruiting - verified July 2017

http://ift.tt/2tZzGKf